Evidence map›Paper›PMID 34282149›Full record

ReviewNature communications2021

Combating mosquito-borne diseases using genetic control technologies.

Guan-Hong Wang, Stephanie Gamez, Robyn R Raban, John M Marshall, Luke Alphey, Ming Li, Jason L Rasgon, Omar S Akbari

Abstract readReview
In one paragraph

Review in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Spatial Dynamics and Sterilization Range of IncompatibleTropical medicine and infectious disease · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guan-Hong Wang *Division of Biological Sciences, Section of Cell and Developmental Biology, University of California, San Diego, CA, USA.ORCID 0000-0002-4106-6167
Stephanie Gamez *Division of Biological Sciences, Section of Cell and Developmental Biology, University of California, San Diego, CA, USA.ORCID 0000-0003-0665-0066
Robyn R Raban *Division of Biological Sciences, Section of Cell and Developmental Biology, University of California, San Diego, CA, USA.
John M MarshallDivision of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, CA, USA.ORCID 0000-0003-0603-7341
Luke AlpheyArthropod Genetics, The Pirbright Institute, Pirbright, UK.
Ming LiDivision of Biological Sciences, Section of Cell and Developmental Biology, University of California, San Diego, CA, USA.
Jason L RasgonDepartment of Entomology, The Pennsylvania State University, University Park, PA, USA.ORCID 0000-0002-4050-8429
Omar S AkbariDivision of Biological Sciences, Section of Cell and Developmental Biology, University of California, San Diego, CA, USA. oakbari@ucsd.edu.ORCID 0000-0002-6853-9884

Funding

Development of synthetic viral circuitry to regulate viruses in mosquito disease vectorsDP2AI152071 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AKBARI, OMAR SULTAN · 2019 to 2019
$2.4M
Precision guided SIT for the control of vector-borne diseaseR01AI151004 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AKBARI, OMAR SULTAN · 2020 to 2024
$2.3M
Wolbachia-induced enhancement of human arboviral pathogensR01AI116636 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI RASGON, JASON L · 2016 to 2020
$1.9M
Transcriptome engineering technologies for the development of antiviral effectors in mosquitoesR21AI149161 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AKBARI, OMAR SULTAN · 2020 to 2021
$434k
Biotechnology and Biological Sciences Research Council BBS/E/I/00007033NIAID NIH HHS DP2 AI152071NIAID NIH HHS R01 AI116636NIAID NIH HHS R01 AI151004NIAID NIH HHS R21 AI149161
6 · The paper itself

Abstract

Mosquito-borne diseases, such as dengue and malaria, pose significant global health burdens. Unfortunately, current control methods based on insecticides and environmental maintenance have fallen short of eliminating the disease burden. Scalable, deployable, genetic-based solutions are sought to reduce the transmission risk of these diseases. Pathogen-blocking Wolbachia bacteria, or genome engineering-based mosquito control strategies including gene drives have been developed to address these problems, both requiring the release of modified mosquitoes into the environment. Here, we review the latest developments, notable similarities, and critical distinctions between these promising technologies and discuss their future applications for mosquito-borne disease control.

Indexed as

InsecticidesAnimalsAnimals, Genetically ModifiedCRISPR-Cas SystemsFemaleHumansMalariaMaleMosquito ControlMosquito VectorsNucleic Acid Amplification TechniquesPest Control, BiologicalVector Borne DiseasesWolbachiaInsecticides

Identifiers

PMID34282149
PMCPMC8290041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.